| Primary information |
|---|
| ID | 17378 |
| Uniprot ID | P08112 |
| Description | Transforming growth factor beta-2 proprotein (BSC-1 cell growth inhibitor) (Polyergin) [Cleaved into- Latency-associated peptide (LAP); Transforming growth factor beta-2 (TGF-beta-2)] |
| Organism | Homo sapiens |
| Txonomy | Chlorocebus ; Cercopithecinae; Cercopithecidae ; Cercopithecoidea ; Catarrhini; Simiiformes ; Haplorrhini ; Primates ; Euarchontoglires; Boreoeutheria; Eutheria; Theria; Mammalia ; Amniota; Tetrapoda; Dipnotetrapodomorpha; Sarcopterygii; Euteleostomi; Teleostomi; Gnathostomata; Vertebrata; Craniata ; Chordata ; Deuterostomia; Bilateria; Eumetazoa; Metazoa ; Opisthokonta; Eukaryota ; cellular organisms |
| Subcellular Location | [Latency-associated peptide]- Secreted; extracellular space; extracellular matrix |
| Developmental Stage | NA |
| Similarity | NA |
| Tissue Specificity | NA |
| Post Translational Modification | [Transforming growth factor beta-2]- The precursor proprotein is cleaved in the Golgi apparatus to form Transforming growth factor beta-2 (TGF-beta-2) and Latency-associated peptide (LAP) chains; whic |
| Function | [Transforming growth factor beta-2 proprotein]- Precursor of the Latency-associated peptide (LAP) and Transforming growth factor beta-2 (TGF-beta-2) chains; which constitute the regulatory and active subunit of TGF-beta-2; respectively. |
| Length | 414 |
| Molecular Weight | 47748 |
| Name | Transforming growth factor beta-2 proprotein |
| Sequence | LSTCSTLDMDQFMRKRIEAIRGQILSKLKLTSPPEDYPEPEEVPPEVISIYNSTRDLLQEKASRRAAACERERSDEEYYAKEVYKIDMPPFFPSENAIPPTFYRPYFRIVRFDVSAMEKNASNLVKAEFRVFRLQNPKARVPEQRIELYQILKSKDLTSPTQRYIDSKVVKTRAEGEWLSFDVTDAVHEWLHHKDRNLGFKISLHCPCCTFVPSNNYIIPNKSEELEARFAGIDGTSTYTSGDQKTIKSTRKKNSGKTPHLLLMLLPSYRLESQQTNRRKKRALDAAYCFRNVQDNCCLRPLYIDFKRDLGWKWIHEPKGYNANFCAGACPYLWSSDTQHSRVLSLYNTINPEASASPCCVSQDLEPLTILYYIGKTPKIEQLSNMIVKSCKCS |
| Sequence map | 26-54 |
| PDB ID | NA |
| Drugpedia | NA |
| Receptor | P37173; Q03167; Q6EMK4 |
| Domain | NA |
| Pharmaceutical Use | NA
|